Celiac disease is an immune-mediated enteropathy triggered by gluten in genetically predisposed individuals (HLA-DQ2/DQ8), with a global seroprevalence of approximately 1.4%. However, only one in four ...
Short seller’s Characterization of ASCENIV’s Competitive Position Reflects Blatant Misunderstanding of ADMA’s Business and ...
Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, ...
Artificial wombs are recreating pregnancy outside the body, keeping premature life developing in controlled environments.
Short seller's Characterization of ASCENIV's Competitive Position Reflects Blatant Misunderstanding of ADMA's Business and ...
Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured a contract award valued at approximately $54 million USD to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV ...
Whether you’re exploring local green spaces, walking your dog, gardening or catching up on yardwork, spring is sure to get ...
Gilead Sciences is paying $1.67 billion for a T-cell engager (TCE) company via a front-loaded deal that could also give new ...
Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...
ETHealthworld.com brings latest metropolis healthcare news, views and updates from all top sources for the Indian Health industry.
MOORESVILLE, NC - April 06, 2026 - PRESSADVANTAGE - Advanced Industrial, a precision CNC plastics machining company ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that KEYTRUDA® (pembrolizumab), in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results